Microfluidic Squeezing Enables MHC Class I Antigen Presentation by Diverse Immune Cells to Elicit CD8+ T Cell Responses with Antitumor Activity.
Saved in:
| Title: | Microfluidic Squeezing Enables MHC Class I Antigen Presentation by Diverse Immune Cells to Elicit CD8+ T Cell Responses with Antitumor Activity. |
|---|---|
| Authors: | Booty MG; SQZ Biotechnologies, Watertown, MA., Hlavaty KA; SQZ Biotechnologies, Watertown, MA., Stockmann A; SQZ Biotechnologies, Watertown, MA., Ozay EI; SQZ Biotechnologies, Watertown, MA., Smith C; SQZ Biotechnologies, Watertown, MA., Tian L; SQZ Biotechnologies, Watertown, MA., How E; SQZ Biotechnologies, Watertown, MA., Subramanya D; SQZ Biotechnologies, Watertown, MA., Venkitaraman A; SQZ Biotechnologies, Watertown, MA., Yee C; SQZ Biotechnologies, Watertown, MA., Pryor O; SQZ Biotechnologies, Watertown, MA., Volk K; SQZ Biotechnologies, Watertown, MA., Blagovic K; SQZ Biotechnologies, Watertown, MA., Vicente-Suarez I; SQZ Biotechnologies, Watertown, MA., Yarar D; SQZ Biotechnologies, Watertown, MA., Myint M; SQZ Biotechnologies, Watertown, MA., Merino A; SQZ Biotechnologies, Watertown, MA., Chow J; SQZ Biotechnologies, Watertown, MA., Abdeljawad T; SQZ Biotechnologies, Watertown, MA., An H; SQZ Biotechnologies, Watertown, MA., Liu S; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA., Mao S; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA., Heimann M; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA., Talarico L; SQZ Biotechnologies, Watertown, MA., Jacques MK; SQZ Biotechnologies, Watertown, MA., Chong E; SQZ Biotechnologies, Watertown, MA., Pomerance L; SQZ Biotechnologies, Watertown, MA., Gonzalez JT; SQZ Biotechnologies, Watertown, MA., von Andrian UH; Department of Immunology, Harvard Medical School, Boston, MA.; Ragon Institute of MGH, MIT, and Harvard, Boston, MA.; Center for Immune Imaging at Harvard Medical School, Boston, MA., Jensen KF; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA., Langer R; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA.; David Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA., Knoetgen H; Roche Innovation Center Basel, Roche Pharmaceutical Research and Early Development, Basel, Switzerland; and., Trumpfheller C; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, Schlieren, Switzerland., Umaña P; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development, Schlieren, Switzerland., Bernstein H; SQZ Biotechnologies, Watertown, MA., Sharei A; SQZ Biotechnologies, Watertown, MA., Loughhead SM; SQZ Biotechnologies, Watertown, MA; scott.loughhead@sqzbiotech.com. |
| Source: | Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2022 Feb 15; Vol. 208 (4), pp. 929-940. Date of Electronic Publication: 2022 Jan 28. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 2985117R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1550-6606 (Electronic) Linking ISSN: 00221767 NLM ISO Abbreviation: J Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
